PDPN and cancer: In both cases, inhibition of RhoA modulation led to reduced cell motility, strengthening the notion that the regulation of RhoA activity is causally involved in the pro-migratory phenotype observed in podoplanin-expressing cancer cells (Martin-Villar et al, 2006; Wicki et al, 2006).